Screening for hepatocellular carcinoma - IAGH

More documents

Recommendations

Info

Perinatal Transmission riskMother: HBsAg +, HBeAg +70-90% risk of chronic HBV infectionby age 6 months withoutimmunoprophylaxis30% not infected perinatally are positive byage 4(Beasley, J Inf Dis, 1984)
Outcome of perinatal HBV Exposure and Maternal HBV DNABurk et al:- 773 HBsAg positive- Odds ratio 147 persistently infected infantIf the mother is:- HBeAg positive- HBV DNA level > 8 x 10 8 IU/mL- Elevated HBV DVA higher risk, even with HBeAgnegativeBurk RD, et al. J infect Dis 1994;170:1418-23
Page 5 and 6: Population-based Cancer Registry Da
Page 7: Rising Incidence of HCC(Last 2 deca
Page 10 and 11: Number of casesOverall trend in the
Page 12 and 13: Why is HCC Incidence Rising?Increas
Page 14 and 15: 1. HBVRisk factor of HCC in Iran•
Page 16 and 17: Low incidence of HCC In Iran??• M
Page 18 and 19: Multiple logistic regression analys
Page 20 and 21: HBV In PregnancyContinue the case:
Page 24 and 25: Risk with High Maternal HBV DNA- 31
Page 26 and 27: Teatment During PregnancyOutcomes:-
Page 28 and 29: Treatment Option for Chronic HBVInt
Page 30 and 31: AFP In PregnancyAFP produced byYolk
Page 32 and 33: Screening for chronic diseaseMust b
Page 34 and 35: • Imaging studies• Ultrasound*H
Page 36 and 37: ScreeningUS Sensitivity and Specifi
Page 38 and 39: HCC Screening: clinical studiesStud
Page 40 and 41: Zhang BH et al, J Cancer Res Clin O
Page 42 and 43: Zhang BH et al, J Cancer Res Clin O
Page 44 and 45: AASLD Recommendation for HCC survei

Screening for hepatocellular carcinoma - IAGH

Create successful ePaper yourself

Delete template?

Save as template?